Maternal citrulline supplementation prevents prenatal dexamethasone-induced programmed hypertension

References

• Ozanne SE, Constância M. Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab 2007;3:539–546.
   PubMedGoogle Scholar
• Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3:CD004454.
   Google Scholar
• Seckl JR, Holmes MC. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal ‘programming’ of adult pathophysiology. Nat Clin Pract Endocrinol Metab 2007;3:479–488.
   PubMedGoogle Scholar
• Drake AJ, Tang JI, Nyirenda MJ. Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease. Clin Sci (Lond) 2007;113:219–232.
   PubMed Web of Science ®Google Scholar
• Ortiz LA, Quan A, Zarzar F, Weinberg A, Baum M. Prenatal dexamethasone programs hypertension and renal injury in the rat. Hypertension 2003;41:328–334.
   PubMed Web of Science ®Google Scholar
• Ojeda NB, Grigore D, Alexander BT. Developmental programming of hypertension: insight from animal models of nutritional manipulation. Hypertension 2008;52:44–50.
   PubMedGoogle Scholar
• Tain YL, Huang LT. Asymmetric dimethylarginine: clinical applications in pediatric medicine. J Formos Med Assoc 2011;110:70–77.
   PubMed Web of Science ®Google Scholar
• Tain YL, Hsieh CS, Lin IC, Chen CC, Sheen JM, Huang LT. Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: the impact of nitric oxide pathway. Nitric Oxide 2010;23:34–41.
   PubMedGoogle Scholar
• Tain YL, Lee WC, Hsu CN, Lee WC, Huang LT, Lee CT, Lin CY. Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers. PLoS One 2013;8:e55420.
   PubMedGoogle Scholar
• Bagby SP. Maternal nutrition, low nephron number, and hypertension in later life: pathways of nutritional programming. J Nutr 2007;137:1066–1072.
   PubMed Web of Science ®Google Scholar
• Pham TD, MacLennan NK, Chiu CT, Laksana GS, Hsu JL, Lane RH. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol 2003; 285:R962–R970.
   PubMed Web of Science ®Google Scholar
• Welham SJ, Wade A, Woolf AS. Protein restriction in pregnancy is associated with increased apoptosis of mesenchymal cells at the start of rat metanephrogenesis. Kidney Int 2002;61:1231–1242.
   PubMed Web of Science ®Google Scholar
• Abdel-Hakeem AK, Henry TQ, Magee TR, Desai M, Ross MG, Mansano RZ, et al. Mechanisms of impaired nephrogenesis with fetal growth restriction: altered renal transcription and growth factor expression. Am J Obstet Gynecol 2008;199:252.e1–e7.
   Google Scholar
• Alwasel SH, Ashton N. Prenatal programming of renal sodium handling in the rat. Clin Sci (Lond) 2009;117:75–84.
   PubMedGoogle Scholar
• Dagan A, Kwon HM, Dwarakanath V, Baum M. Effect of renal denervation on prenatal programming of hypertension and renal tubular transporter abundance. Am J Physiol Renal Physiol 2008;295:F29–F34.
   PubMed Web of Science ®Google Scholar
• Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol 2008;65:51–59.
   PubMed Web of Science ®Google Scholar
• Koeners MP, van Faassen EE, Wesseling S, de Sain-van der Velden M, Koomans HA, Braam B, Joles JA. Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension 2007;50:1077–1084.
   PubMed Web of Science ®Google Scholar
• Lassala A, Bazer FW, Cudd TA, Li P, Li X, Satterfield MC, et al. Intravenous administration of L-citrulline to pregnant ewes is more effective than L-arginine for increasing arginine availability in the fetus. J Nutr 2009;139:660–665.
   PubMedGoogle Scholar
• Hurwitz R, Kretchmer N. Development of arginine- synthesizing enzymes in mouse intestine. Am J Physiol 1986;251:G103–G110.
   PubMedGoogle Scholar
• Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Bénazeth S, Cynober L. Almost all about citrulline in mammals. Amino Acids 2005;29:177–205.
   PubMed Web of Science ®Google Scholar
• Chien SJ, Lin KM, Kuo HC, Huang CF, Lin YJ, Huang LT, Tain YL. Two different approaches to restore renal nitric oxide and prevent hypertension in young spontaneously hypertensive rats: l-citrulline and nitrate. Transl Res 2014;163:43–52.
   PubMed Web of Science ®Google Scholar
• Sherman RC, Langley-Evans SC. Antihypertensive treatment in early postnatal life modulates prenatal dietary influences upon blood pressure in the rat. Clin Sci (Lond) 2000;98:269–275.
   PubMed Web of Science ®Google Scholar
• Hsu CN, Lee CT, Huang LT, Tain YL. Aliskiren in early postnatal life prevents hypertension and reduces asymmetric dimethylarginine in offspring exposed to maternal caloric restriction. J Renin Angiotensin Aldosterone Syst 2014 (in press).
   Google Scholar
• Chen S, Bellew C, Yao X, Stefkova J, Dipp S, Saifudeen Z, et al. Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. J Biol Chem 2011;286:32775–32789.
   PubMedGoogle Scholar
• Song R, Van Buren T, Yosypiv IV. Histone deacetylases are critical regulators of the renin-angiotensin system during ureteric bud branching morphogenesis. Pediatr Res 2010;67: 573–578.
   PubMedGoogle Scholar